Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F B König

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Neurology|June 3, 2009
Remyelination capacity of the MS brain decreases with disease chronicityT Goldschmidt, J Antel, F B König, et al.
Journal of Neuroinflammation|August 31, 2017
Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysisS Jarius, F B König, I Metz, et al.
Journal of Neurology|April 8, 2026
An autoantibody signature predictive for multiple sclerosis: evidence at the protein level and association with histopathological lesion typesS Jarius, K Ruprecht, I Metz, et al.
Der Nervenarzt|December 13, 2005
[Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses: clinical experience with 16 patients]S Schilling, R A Linker, F B König, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Neurology|June 3, 2009
Remyelination capacity of the MS brain decreases with disease chronicityT Goldschmidt, J Antel, F B König, et al.
Journal of Neuroinflammation|August 31, 2017
Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysisS Jarius, F B König, I Metz, et al.
Journal of Neurology|April 8, 2026
An autoantibody signature predictive for multiple sclerosis: evidence at the protein level and association with histopathological lesion typesS Jarius, K Ruprecht, I Metz, et al.
Der Nervenarzt|December 13, 2005
[Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses: clinical experience with 16 patients]S Schilling, R A Linker, F B König, et al.
Pageof 1